Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Dyslipidemia is associated with a prothrombotic phenotype; however, the mechanisms responsible for enhanced platelet reactivity remain unclear. Proatherosclerotic lipid abnormalities are associated with both enhanced oxidant stress and the generation of biologically active oxidized lipids, including potential ligands for the scavenger receptor CD36, a major platelet glycoprotein. Using multiple mouse in vivo thrombosis models, we now demonstrate that genetic deletion of Cd36 protects mice from hyperlipidemia-associated enhanced platelet reactivity and the accompanying prothrombotic phenotype. Structurally defined oxidized choline glycerophospholipids that serve as high-affinity ligands for CD36 were at markedly increased levels in the plasma of hyperlipidemic mice and in the plasma of humans with low HDL levels, were able to bind platelets via CD36 and, at pathophysiological levels, promoted platelet activation via CD36. Thus, interactions of platelet CD36 with specific endogenous oxidized lipids play a crucial role in the well-known clinical associations between dyslipidemia, oxidant stress and a prothrombotic phenotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Platelet hyperreactivity and thrombosis risk are enhanced in the setting of numerous conditions associated with atherosclerotic heart disease, such as hyperlipidemia, oxidant stress, and hyperglycemia (Podrez et al., 2007; Chen et al., 2008; Zhu et al., 2012a).”
From Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk (2016) · cites this paper as Podrez et al., 2007
Citations
Cites
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394 · cited 1×
“Because anti-inflammatory and antioxidant effects of HDL are well documente”
BackgroundFebbraio, M., Hajjar, D. P., & Silverstein, R. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14006 · Cited by 1,193 · cited 1×
“CD36 is implicated in a variety of pathological conditions, including atherosclerosis, diabetes and innate immunit”
BackgroundSelf-citationFebbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,044 · cited 1×
“Absence of CD36 in a mouse model of atherogenesis results in significant inhibition of atherosclerosi”
BackgroundSelf-citationCirculating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E
Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., Littman, D. R., Weber, C., & Ley, K. (2003) · Nature Medicine · doi:10.1038/nm810 · Cited by 1,005 · cited 1×
“Platelet P-selectin mediates the formation of platelet-monocyte aggregates, which have been implicated in several vascular disease processe”
BackgroundCD36 is a sensor of diacylglycerides
Hoebe, K., Georgel, P., Rutschmann, S., Du, X., Mudd, S., Crozat, K., Sovath, S., Shamel, L., Hartung, T., Zähringer, U., et al. (2005) · Nature · doi:10.1038/nature03253 · Cited by 873 · cited 1×
“To address any potential issues related to the mixed genetic background of the Cd36 −/− and Apoe −/− Cd36 −/− mice, we used independently generated, CD36-deficient 'oblivious' mic”
MethodWatson, A. D., Leitinger, N., Navab, M., Faull, K. F., Hörkkö, S., Witztum, J. L., Palinski, W., Schwenke, D., Salomon, R. G., Sha, W., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13597 · Cited by 753
Self-citationCD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism
André, P., Prasad, K. S. S., Denis, C. V., He, M., Papalia, J. M., Hynes, R. O., Phillips, D. R., & Wagner, D. D. (2002) · Nature Medicine · doi:10.1038/nm0302-247 · Cited by 726
Platelet Function in Hyperlipoproteinemia
Carvalho, A. C. A., Colman, R. W., & Lees, R. S. (1974) · New England Journal of Medicine · doi:10.1056/nejm197402212900805 · Cited by 679
Platelet Hyperreactivity and Prognosis in Survivors of Myocardial Infarction
Trip, M. D., Cats, V. M., van Capelle, F. J. L., & Vreeken, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222201 · Cited by 617
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
Podrez, E. A., Schmitt, D., Hoff, H. F., & Hazen, S. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5549 · Cited by 492
Self-citationPodrez, E. A., Febbraio, M., Sheibani, N., Schmitt, D., Silverstein, R. L., Hajjar, D. P., Cohen, P. A., Frazier, W. A., Hoff, H. F., & Hazen, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8574 · Cited by 455 · cited 1×
“16 ) and facilitate macrophage foam cell formation through recognition and uptake of oxidized LDL by CD36 (ref”
BackgroundSelf-citationPodrez, E. A., Poliakov, E., Shen, Z., Zhang, R., Deng, Y., Sun, M., Finton, P. J., Shan, L., Gugiu, B., Fox, P. L., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203318200 · Cited by 449 · cited 1×
“We have recently isolated and structurally defined a novel family of atherogenic oxidized choline glycerophospholipids (oxPC CD36 ) that are formed during the oxidization of low-density lipoprotein (LDL) by multiple pathway”
BackgroundSelf-citationLacoste, L., Lam, J. Y. T., Hung, J., Letchacovski, G., Solymoss, C. B., & Waters, D. (1995) · Circulation · doi:10.1161/01.cir.92.11.3172 · Cited by 441
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
Angelillo-Scherrer, A., de Frutos, P. G., Aparicio, C., Melis, E., Savi, P., Lupu, F., Arnout, J., Dewerchin, M., Hoylaerts, M. F., Herbert, J.-M., et al. (2001) · Nature Medicine · doi:10.1038/84667 · Cited by 441
Huang, M. M., Bolen, J. B., Barnwell, J. W., Shattil, S. J., & Brugge, J. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7844 · Cited by 406
The role of oxidized phospholipids in atherosclerosis
Berliner, J. A., Leitinger, N., & Tsimikas, S. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800074-jlr200 · Cited by 403
Podrez, E. A., Poliakov, E., Shen, Z., Zhang, R., Deng, Y., Sun, M., Finton, P. J., Shan, L., Febbraio, M., Hajjar, D. P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205924200 · Cited by 386 · cited 1×
“and are present in vivo at sites of enhanced oxidative stres”
BackgroundSelf-citationDrosophila RNAi Screen Reveals CD36 Family Member Required for Mycobacterial Infection
Philips, J. A., Rubin, E. J., & Perrimon, N. (2005) · Science · doi:10.1126/science.1116006 · Cited by 369 · cited 1×
“CD36 is involved in a diverse array of physiological and pathological processes in vivo , including lipid sensing and metabolism, innate immune responses, angiogenesis, uptake of apoptotic cells, atherogenesis and diabete”
BackgroundIncreased Platelet Binding to Circulating Monocytes in Acute Coronary Syndromes
Sarma, J., Laan, C. A., Alam, S., Jha, A., Fox, K. A. A., & Dransfield, I. (2002) · Circulation · doi:10.1161/01.cir.0000015700.27754.6f · Cited by 362 · cited 1×
“Platelet P-selectin mediates the formation of platelet-monocyte aggregates, which have been implicated in several vascular disease processe”
BackgroundEffect of Cholesterol on Production of Thromboxane B2by Platelets in Vitro
Stuart, M. J., Gerrard, J. M., & White, J. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001033020102 · Cited by 321
Aspirin and clopidogrel resistance: an emerging clinical entity
Wang, T. H., Bhatt, D. L., & Topol, E. J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi684 · Cited by 309
Plow, E., McEver, R., Coller, B., Woods, V. J., Marguerie, G., & Ginsberg, M. (1985) · Blood · doi:10.1182/blood.v66.3.724.724 · Cited by 257
A Role for Oxidized Phospholipids in Atherosclerosis
Berliner, J. A., & Watson, A. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058118 · Cited by 229 · cited 1×
“Biologically active oxidized phospholipids can initiate and modulate many of the cellular events attributed to the pathogenesis of atherosclerosi”
BackgroundSimon, D. I., Chen, Z., Seifert, P., Edelman, E. R., Ballantyne, C. M., & Rogers, C. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7811 · Cited by 228
Isolation and characterization of platelet glycoprotein IV (CD36)
Tandon, N. N., Lipsky, R. H., Burgess, W. H., & Jamieson, G. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83272-0 · Cited by 222
Cipollone, F., Mezzetti, A., Porreca, E., Di Febbo, C., Nutini, M., Fazia, M., Falco, A., Cuccurullo, F., & Davì, G. (2002) · Circulation · doi:10.1161/01.cir.0000025419.95769.f0 · Cited by 216
Febbraio, M., Guy, E., & Silverstein, R. L. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000148007.06370.68 · Cited by 177 · cited 1×
“Whereas macrophage CD36 involvement in fatty-streak formation and atherogenesis is well describe”
BackgroundSelf-citationIncreased Levels of Soluble P-Selectin in Hypercholesterolemic Patients
Davı̀, G., Romano, M., Mezzetti, A., Procopio, A., Iacobelli, S., Antidormi, T., Bucciarelli, T., Alessandrini, P., Cuccurullo, F., & Bon, G. B. (1998) · Circulation · doi:10.1161/01.cir.97.10.953 · Cited by 172
CD36 Mediates the Cardiovascular Action of Growth Hormone-Releasing Peptides in the Heart
Bodart, V., Febbraio, M., Demers, A., McNicoll, N., Pohankova, P., Perreault, A., Sejlitz, T., Escher, E., Silverstein, R. L., Lamontagne, D., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000016164.02525.b4 · Cited by 169 · cited 1×
“CD36 is involved in a diverse array of physiological and pathological processes in vivo , including lipid sensing and metabolism, innate immune responses, angiogenesis, uptake of apoptotic cells, atherogenesis and diabete”
BackgroundSelf-citationIncreased thromboxane biosynthesis in type IIa hypercholesterolemia.
Davì, G., Averna, M., Catalano, I., Barbagallo, C., Ganci, A., Notarbartolo, A., Ciabattoni, G., & Patrono, C. (1992) · Circulation · doi:10.1161/01.cir.85.5.1792 · Cited by 166
Sun, M., Finnemann, S. C., Febbraio, M., Shan, L., Annangudi, S. P., Podrez, E. A., Hoppe, G., Darrow, R., Organisciak, D. T., Salomon, R. G., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509769200 · Cited by 165 · cited 1×
“and are present in vivo at sites of enhanced oxidative stres”
BackgroundSelf-citationPrévost, N., Woulfe, D. S., Jiang, H., Stalker, T. J., Marchese, P., Ruggeri, Z. M., & Brass, L. F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404065102 · Cited by 153
Platelet Reactivity Characterized Prospectively
Kabbani, S., Watkins, M. W., Ashikaga, T., Terrien, E. F., Holoch, P. A., Sobel, B. E., & Schneider, D. J. (2001) · Circulation · doi:10.1161/01.cir.104.2.181 · Cited by 145 · cited 1×
“dtd" [ ]> An important role for increased platelet reactivity in the pathophysiology of occlusive arterial thrombi associated with myocardial infarction and stroke is widely recognized, and subjects with increases in various measures of platelet reactivity are at increased prospective risk for coronary events and deat”
BackgroundSalonen, J., Salonen, R. M., Seppänen, K., Rinta-Kiikka, S., Kuukka, M., Korpela, H., Alfthan, G., Kantola, M., & Schalch, W. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.5.1222 · Cited by 124
Phosphocholine as a pattern recognition ligand for CD36
Boullier, A., Friedman, P., Harkewicz, R., Hartvigsen, K., Green, S. R., Almazan, F., Dennis, E. A., Steinberg, D. H., Witztum, J. L., & Quehenberger, O. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400496-jlr200 · Cited by 122
Morita, H., Ikeda, H., Haramaki, N., Eguchi, H., & Imaizumi, T. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.10.061 · Cited by 111
Véricel, E., Januel, C., Carreras, M., Moulin, P., & Lagarde, M. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1046 · Cited by 103 · cited 1×
“Moreover, enhanced platelet reactivity is associated with the accumulation of oxidized lipids in seru”
BackgroundEitzman, D. T., Westrick, R. J., Xu, Z., Tyson, J., & Ginsburg, D. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.7.1831 · Cited by 95 · cited 1×
“Using two different mouse models of hyperlipidemia and several assays for in vivo thrombosis, we confirmed that hyperlipidemia induces a pronounced prothrombotic state; these findings are consistent with prior observations in Apoe −/− mic”
ResultSchäfer, K., Müller, K., Hecke, A., Mounier, E., Goebel, J., Loskutoff, D. J., & Konstantinides, S. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000097766.36623.df · Cited by 86 · cited 1×
“Using two different mouse models of hyperlipidemia and several assays for in vivo thrombosis, we confirmed that hyperlipidemia induces a pronounced prothrombotic state; these findings are consistent with prior observations in Apoe −/− mic”
ResultMaschberger, P., Bauer, M., Baumann-Siemons, J., Zangl, K. J., Negrescu, E. V., Reininger, A. J., & Siess, W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910257199 · Cited by 83 · cited 1×
“, which have previously been implicated in platelet activation by oxidized LD”
BackgroundAdhesive functions of platelets lacking glycoprotein IV (CD36)
Tandon, N., Ockenhouse, C., Greco, N., & Jamieson, G. (1991) · Blood · doi:10.1182/blood.v78.11.2809.2809 · Cited by 81
A Novel Role for CD36 in VLDL-Enhanced Platelet Activation
Englyst, N. A., Taube, J. M., Aitman, T. J., Baglin, T. P., & Byrne, C. D. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1248 · Cited by 66 · cited 1×
“Notably, VLDL increases platelet response to collagen in a CD36-dependent manner; however, the mechanism of this effect remains unclea”
BackgroundKieffer, N., Bettaı̈eb, A., Legrand, C., Coulombel, L., Vainchenker, W., Edelman, L., & BRETON-GORIUS, J. (1989) · Biochemical Journal · doi:10.1042/bj2620835 · Cited by 62
Pearce, S. F. A., Roy, P., NICHOLSON, A. C., Hajjar, D. P., Febbraio, M., & Silverstein, R. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.34875 · Cited by 60 · cited 1×
“The CD36-dependence of these effects was confirmed using a recombinant human CD36–glutathione S -transferase fusion peptide corresponding to amino acids 5–143 of the extracellular domain of CD36 that was shown previously to bind oxLD”
BackgroundSelf-citationKabbani, S., Watkins, M. W., Ashikaga, T., Terrien, E. F., Sobel, B. E., & Schneider, D. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00025-0 · Cited by 37 · cited 1×
“dtd" [ ]> An important role for increased platelet reactivity in the pathophysiology of occlusive arterial thrombi associated with myocardial infarction and stroke is widely recognized, and subjects with increases in various measures of platelet reactivity are at increased prospective risk for coronary events and deat”
BackgroundVanschoonbeek, K., Feijge, M. A. H., Keuren, J. F. W., Hemker, H. C., Lodder, J., Hamulyák, K., Pampus, E. C. M. V., & Heemskerk, J. W. M. (2002) · PubMed · Cited by 27
Thrombin-induced Hyperactivity of Platelets of Young Stroke Patients
Vanschoonbeek, K., Feijge, M. A. H., Keuren, J. F. W., Hemker, H. C., Lodder, J., Hamulyák, K., Pampus, E. C. M. V., & Heemskerk, J. W. M. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613336 · Cited by 24
Cited by
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
“Platelet hyperreactivity and thrombosis risk are enhanced in the setting of numerous conditions associated with atherosclerotic heart disease, such as hyperlipidemia, oxidant stress, and hyperglycemia (Podrez et al., 2007; Chen et al., 2008; Zhu et al., 2012).”
Self-citationFree Radical Lipid Peroxidation: Mechanisms and Analysis
Yin, H., Xu, L., & Porter, N. A. (2011) · Chemical Reviews · doi:10.1021/cr200084z · Cited by 1,937
Mechanisms of Thrombus Formation
Furie, B., & Furie, B. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801082 · Cited by 1,926
CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
Silverstein, R. L., & Febbraio, M. (2009) · Science Signaling · doi:10.1126/scisignal.272re3 · Cited by 1,141
Self-citationTriggers, targets and treatments for thrombosis
Mackman, N. (2008) · Nature · doi:10.1038/nature06797 · Cited by 1,188
“A recent study showed that oxidized low-density lipoproteins activate platelets by binding to CD36 and that the prothrombotic phenotype of mice deficient in apolipoprotein E, which have high concentrations of low-density lipoprotein in the circulation, is reduced by deletion of Cd36 (ref”
Background
Metadata
- Authors
- Podrez, E. A., Byzova, T. V., Febbraio, M., Salomon, R. G., Ma, Y., Valiyaveettil, M., Poliakov, E., Sun, M., Finton, P. J., Curtis, B. R., Chen, J., Zhang, R., Silverstein, R. L., & Hazen, S. L.
- Affiliations
- Cleveland Clinic (US)
- Case Western Reserve University (US)
- Versiti Blood Center of Wisconsin (US)
- Corresponding author
- Podrez, Eugene A
- ORCID
- Venue
- Nature Medicine
- Published
- 2007-08-26
- Volume
- 13
- Issue
- 9
- Pages
- 1086-1095
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC3042888
- OpenAlex
- W2029684068
- Cited by
- 513
- References
- 47
- Citations by year
- 2026: 25 · 2025: 24 · 2024: 18 · 2023: 29 · 2022: 32 · 2021: 27 · 2020: 27 · 2019: 25 · 2018: 23 · 2017: 24 · 2016: 16 · 2015: 27 · 2014: 26 · 2013: 28 · 2012: 36
- FWCI
- 19.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL071625., P01HL046403, HL053315, HL 073311, HL076491, HL-072942, R01HL070083, P50 HL-81011, HL077107, HL077213, P01HL072942, P50HL077107, P01HL077107, R01HL077213, P01HL076491, HL 70621, HL70083, R01HL053315, HL-46403, P01HL073311, R01HL070621, P50HL081011, R01HL071625)
- National Center for Research Resources (M01RR018390)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- hyperlipidemia, oxidative stress, prothrombotic phenotype, oxidized lipids, platelet activation, scavenger receptors, dyslipidemia, thrombosis, HDL cholesterol
- MeSH terms
- Animals, Blood Platelets, Humans, Hyperlipidemias, Male, Phenotype, Phospholipids, Prothrombin, Thrombosis, Platelet Activation, Antigens, CD, Gene Deletion, Mice, Knockout, Oxidative Stress, CD36 Antigens, Dyslipidemias, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.